참고문헌
- Williams R: Global challenges in liver disease. Hepatology 44;521-526, 2006 https://doi.org/10.1002/hep.21347
- O'Shea RS, Dasarathy S, McCullough AJ: Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology: Alcoholic liver disease. Hepatology 51;307-328, 2010 https://doi.org/10.1002/hep.23258
- Jeong WI, Gao B: Innate immunity and alcoholic liver fibrosis. J Gastroenterol Hepatol 23(Suppl 1);S112-S118, 2008 https://doi.org/10.1111/j.1440-1746.2007.05274.x
- Purohit V, Gao B, Song BJ: Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33;191-205, 2009 https://doi.org/10.1111/j.1530-0277.2008.00827.x
- Purohit V, Gao B, Song BJ: Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33;191-205, 2009 https://doi.org/10.1111/j.1530-0277.2008.00827.x
- Gao B, Jeong WI, Tian Z: Liver: An organ with predominant innate immunity. Hepatology 47;729-736, 2008
- Racanelli V, Rehermann B: The liver as an immunological organ. Hepatology 43(2 Suppl 1);S54-S62, 2006 https://doi.org/10.1002/hep.21060
- Crispe IN: The liver as a lymphoid organ. Annu Rev Immunol 27;147-163, 2009 https://doi.org/10.1146/annurev.immunol.021908.132629
- Doherty DG, O'Farrelly C: Innate and adaptive lymphoid cells in the human liver. Immunol Rev 174;5-20, 2000 https://doi.org/10.1034/j.1600-0528.2002.017416.x
- Jeong WI, Osei-Hyiaman D, Park O, Liu J, Batkai S, Mukhopadhyay P, Horiguchi N, Harvey-White J, Marsicano G, Lutz B, Gao B, Kunos G: Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7;227-235, 2008 https://doi.org/10.1016/j.cmet.2007.12.007
- Jeong WI, Park O, Gao B: Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134;248-258, 2008 https://doi.org/10.1053/j.gastro.2007.09.034
- Mandrekar P, Szabo G: Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50;1258-1266, 2009 https://doi.org/10.1016/j.jhep.2009.03.007
- Otani K, Korenaga M, Beard MR, Li K, Qian T, Showalter LA, Singh AK, Wang T, Weinman SA: Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 128;96-107, 2005 https://doi.org/10.1053/j.gastro.2004.10.045
- Lieber CS: Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34;9-19, 2004 https://doi.org/10.1016/j.alcohol.2004.07.008
- Crabb DW: Recent developments in alcoholism: the liver. Recent Dev Alcohol 11;207-230, 1993
- Fromenty B, Berson A, Pessayre D: Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 26(Suppl 1);13-22, 1997 https://doi.org/10.1016/S0168-8278(97)82328-8
- Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Nagai R, Ishibashi S, Yamada N: Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/ Lep(ob) mice. J Biol Chem 277;19353-19357, 2002 https://doi.org/10.1074/jbc.M201584200
- You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW: The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127;1798-1808, 2004 https://doi.org/10.1053/j.gastro.2004.09.049
- Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T: Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 273;29577- 29585, 1998 https://doi.org/10.1074/jbc.273.45.29577
- Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I: Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38;123- 132, 2003
- Nagy LE: Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood) 228;882-890, 2003 https://doi.org/10.1177/153537020322800803
- Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS: Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112;917-920, 1990 https://doi.org/10.7326/0003-4819-112-12-917
- Lin HZ, Yang SQ, Zeldin G, Diehl AM: Chronic ethanol consumption induces the production of tumor necrosis factor- alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res 22(5 Suppl);231S-237S, 1998 https://doi.org/10.1111/j.1530-0277.1998.tb04008.x
- Pritchard MT, McMullen MR, Stavitsky AB, Cohen JI, Lin F, Medof ME, Nagy LE: Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132;1117-1126, 2007 https://doi.org/10.1053/j.gastro.2007.01.053
- Ji C, Deng Q, Kaplowitz N: Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology 40;442-451, 2004 https://doi.org/10.1002/hep.20309
- Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG: Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117;942-952, 1999 https://doi.org/10.1016/S0016-5085(99)70354-9
- Lawler JF Jr, Yin M, Diehl AM, Roberts E, Chatterjee S: Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem 273;5053-5059, 1998 https://doi.org/10.1074/jbc.273.9.5053
- Endo M, Masaki T, Seike M, Yoshimatsu H: TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood) 232;614-621, 2007
- Kang L, Sebastian BM, Pritchard MT, Pratt BT, Previs SF, Nagy LE: Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol Clin Exp Res 31;1581-1588, 2007 https://doi.org/10.1111/j.1530-0277.2007.00452.x
- El-Assal O, Hong F, Kim WH, Radaeva S, Gao B: IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol Immunol 1;205-211, 2004
- Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B: Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40;933-941, 2004 https://doi.org/10.1002/hep.20400
- Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, Lafdil F, Osei-Hyiaman D, Moh A, Fu XY, Pacher P, Kunos G, Gao B: Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134;1148-1158, 2008 https://doi.org/10.1053/j.gastro.2008.01.016
- Radaeva S, Wang L, Radaev S, Jeong WI, Park O, Gao B: Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol 293;G809- G816, 2007 https://doi.org/10.1152/ajpgi.00212.2007
- Jeong WI, Park O, Radaeva S, Gao B: STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 44;1441-1451, 2006 https://doi.org/10.1002/hep.21419
- Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B: Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130;435-452, 2006 https://doi.org/10.1053/j.gastro.2005.10.055
- McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D: Cytokines in alcoholic liver disease. Semin Liver Dis 19; 205-219, 1999 https://doi.org/10.1055/s-2007-1007110
- Szabo G: Consequences of alcohol consumption on host defence. Alcohol Alcohol 34;830-841, 1999 https://doi.org/10.1093/alcalc/34.6.830
- Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 124;783-801, 2006 https://doi.org/10.1016/j.cell.2006.02.015
- Seki E, Brenner DA: Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48;322-335, 2008 https://doi.org/10.1002/hep.22306
- Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG: Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34;101- 108, 2001 https://doi.org/10.1016/S0168-8278(01)81237-X
- Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274;10689-10692, 1999 https://doi.org/10.1074/jbc.274.16.10689
- Visintin A, Mazzoni A, Spitzer JA, Segal DM: Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci U S A 98;12156-12161, 2001 https://doi.org/10.1073/pnas.211445098
- Wright SD, Tobias PS, Ulevitch RJ, Ramos RA: Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 170;1231-1241, 1989 https://doi.org/10.1084/jem.170.4.1231
- Uesugi T, Froh M, Arteel GE, Bradford BU, Wheeler MD, Gäbele E, Isayama F, Thurman RG: Role of lipopolysaccharide- binding protein in early alcohol-induced liver injury in mice. J Immunol 168;2963-2969, 2002 https://doi.org/10.4049/jimmunol.168.6.2963
- Yin M, Bradford BU, Wheeler MD, Uesugi T, Froh M, Goyert SM, Thurman RG: Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 166;4737- 4742, 2001 https://doi.org/10.4049/jimmunol.166.7.4737
- Nanji AA, Khettry U, Sadrzadeh SM: Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 205;243-247, 1994 https://doi.org/10.3181/00379727-205-43703
- Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11;373-384, 2010 https://doi.org/10.1038/ni.1863
- Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G: The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48;1224-1231, 2008 https://doi.org/10.1002/hep.22470
- Bautista AP: Neutrophilic infiltration in alcoholic hepatitis. Alcohol 27;17-21, 2002 https://doi.org/10.1016/S0741-8329(02)00206-9
- Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A, Kadiiska MB, Connor HD, Mason RP, Segal BH, Bradford BU, Holland SM, Thurman RG: NADPH oxidase- derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 106;867-872, 2000 https://doi.org/10.1172/JCI9020
- Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE: Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 79;1348- 1356, 2006 https://doi.org/10.1189/jlb.1005613
- Wheeler MD, Kono H, Yin M, Rusyn I, Froh M, Connor HD, Mason RP, Samulski RJ, Thurman RG: Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats. Gastroenterology 120;1241-1250, 2001 https://doi.org/10.1053/gast.2001.23253
- Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I: High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57;3090-3098, 2008 https://doi.org/10.2337/db08-0564
- Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS: Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 173;3589-3593, 2004 https://doi.org/10.4049/jimmunol.173.6.3589
- Friedman SL: Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88;125-172, 2008 https://doi.org/10.1152/physrev.00013.2007
- Melhem A, Muhanna N, Bishara A, Alvarez CE, Ilan Y, Bishara T, Horani A, Nassar M, Friedman SL, Safadi R: Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol 45;60-71, 2006 https://doi.org/10.1016/j.jhep.2005.12.025
- Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ: Activated stellate cells express the TRAIL receptor- 2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 37;87-95, 2003 https://doi.org/10.1053/jhep.2003.50002
- Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A: Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23;1189-1199, 1996 https://doi.org/10.1002/hep.510230538
- Park O, Jeong WI, Wang L, Wang H, Lian ZX, Gershwin ME, Gao B: Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 49;1683-1694, 2009 https://doi.org/10.1002/hep.22813
- Laso FJ, Madruga JI, Giron JA, Lopez A, Ciudad J, San Miguel JF, Alvarez-Mon M, Orfao A: Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 25;1096-1100, 1997 https://doi.org/10.1002/hep.510250508
- Pan HN, Sun R, Jaruga B, Hong F, Kim WH, Gao B: Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis. Alcohol Clin Exp Res 30;1615-1623, 2006 https://doi.org/10.1111/j.1530-0277.2006.00194.x
- Szabo G, Mandrekar P: A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 33;220- 232, 2009 https://doi.org/10.1111/j.1530-0277.2008.00842.x
- Szabo G, Mandrekar P, Girouard L, Catalano D: Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production. Alcohol Clin Exp Res 20;900-907, 1996 https://doi.org/10.1111/j.1530-0277.1996.tb05269.x
- Jaruga B, Hong F, Kim WH, Sun R, Fan S, Gao B: Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-kappaB and STAT3 signaling pathways. Am J Physiol Gastrointest Liver Physiol 287;G471-G479, 2004 https://doi.org/10.1152/ajpgi.00018.2004
- Minagawa M, Deng Q, Liu ZX, Tsukamoto H, Dennert G: Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 126;1387-1399, 2004 https://doi.org/10.1053/j.gastro.2004.01.022
피인용 문헌
- Effects of Live Lactobacillus paracasei on Plasma Lipid Concentration in Rats Fed an Ethanol-Containing Diet vol.76, pp.2, 2010, https://doi.org/10.1271/bbb.110390
- Lymphocyte subsets in alcoholic liver disease vol.5, pp.2, 2013, https://doi.org/10.4254/wjh.v5.i2.46
- Characterization of an alcoholic hepatic steatosis model induced by ethanol and high-fat diet in rats vol.58, pp.3, 2010, https://doi.org/10.1590/s1516-8913201500294
- Suppression of Natural Killer Cell Activity by Regulatory NKT10 Cells Aggravates Alcoholic Hepatosteatosis vol.8, pp.None, 2010, https://doi.org/10.3389/fimmu.2017.01414
- Lactic Acid Bacteria Isolated from Japanese Fermented Fish (Funa-Sushi) Inhibit Mesangial Proliferative Glomerulonephritis by Alcohol Intake with Stress vol.2018, pp.None, 2010, https://doi.org/10.1155/2018/6491907
- Flow cytometric analysis of lymphocyte subsets in alcoholic liver disease vol.33, pp.1, 2010, https://doi.org/10.4103/jms.jms_43_18
- KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation vol.17, pp.3, 2010, https://doi.org/10.5114/aoms.2019.84410